⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7088976 | 0.73 | — | — | |
| SCHEMBL5162413 | 0.71 | — | — | |
| SCHEMBL424979 | 0.71 | — | — | |
| SCHEMBL6980698 | 0.71 | — | — | |
| SCHEMBL2783226 | 0.69 | — | — | |
| SCHEMBL11316277 | 0.69 | — | — | |
| SCHEMBL17035591 | 0.69 | — | — | |
| Dimethyl Sulfone SCHEMBL7897755 | 0.68 | — | — | |
| SCHEMBL5639323 | 0.67 | — | — | |
| SCHEMBL1067771 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1724278-B1 | NITROGENOUS FUSED-RING DERIVATIVES, MEDICINAL COMPOSITIONS CONTAINING THE DERIVATIVES, AND USE THEREOF AS DRUGS | KISSEI PHARMACEUTICAL (JP) | 2014-05-07 | — | — | EP | disclosed |
| US-8703935-B2 | Method of producing a metal phthalocyanine compound, and method of producing a phthalocyanine compound and an analogue thereof | FUJIFILM CORPORATION (JP) | 2014-04-22 | — | — | US | disclosed |
| US-20130012697-A1 | METHOD OF PRODUCING A METAL PHTHALOCYANINE COMPOUND, AND METHOD OF PRODUCING A PHTHALOCYANINE COMPOUND AND AN ANALOGUE THEREOF | FUJIFILM CORPORATION (JP) | 2013-01-10 | — | — | US | disclosed |
| US-8299240-B2 | Method of producing a metal phthalocyanine compound, and method of producing a phthalocyanine compound and an analogue thereof | FUJIFILM CORPORATION (JP) | 2012-10-30 | — | — | US | disclosed |
| EP-1940967-B1 | METHOD OF PRODUCING A METAL PHTHALOCYANINE COMPOUND, AND METHOD OF PRODUCING A PHTHALOCYANINE COMPOUND AND AN ANALOGUE THEREOF | FUJIFILM CORP (JP) | 2012-10-17 | — | — | EP | disclosed |
| EP-1609798-B1 | FUSED HETEROCYCLIC DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND MEDICINAL USE THEREOF | KISSEI PHARMACEUTICAL (JP) | 2012-05-09 | — | — | EP | disclosed |
| EP-1609798-A9 | FUSED HETEROCYCLIC DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND MEDICINAL USE THEREOF | Kissei Pharmaceutical Co., Ltd. (JP) | 2012-01-11 | — | — | EP | disclosed |
| US-8058245-B2 | Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof | KISSEI PHARMACEUTICAL CO., LTD. (JP) | 2011-11-15 | — | — | US | disclosed |
| EP-1984454-B1 | METHOD OF MANUFACTURING A PHTHALOCYANINE COMPOUND | FUJIFILM CORP (JP) | 2011-10-26 | — | — | EP | disclosed |
| US-7998975-B2 | Sodium dependent glucose transporter inhibition; hyperglycemia associated diseases; 3-glucopyranosyloxy- 1H-indazole and 1H-pyrazolo[3,4-b]pyridine derivatives | KISSEI PHARMACEUTICAL CO., LTD. (JP) | 2011-08-16 | — | — | US | disclosed |
| WO-2007086537-A1 | METHOD OF MANUFACTURING PHTHALOCYANINE COMPOUND | FUJIFILM CORPORATION (JP) | 2007-08-02 | — | — | WO | disclosed |
| WO-2007037039-A1 | METHOD OF PRODUCING A METAL PHTHALOCYANINE COMPOUND, AND METHOD OF PRODUCING A PHTHALOCYANINE COMPOUND AND AN ANALOGUE THEREOF | FUJIFILM CORPORATION (JP) | 2007-04-05 | — | — | WO | disclosed |
| EP-1731524-A1 | PHENOL DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND MEDICINAL USE THEREOF | Kissei Pharmaceutical Co., Ltd. (JP) | 2006-12-13 | — | — | EP | disclosed |
| EP-1724278-A1 | NITROGENOUS FUSED-RING DERIVATIVES, MEDICINAL COMPOSITIONS CONTAINING THE DERIVATIVES, AND USE THEREOF AS DRUGS | Kissei Pharmaceutical Co., Ltd. (JP) | 2006-11-22 | — | — | EP | disclosed |
| EP-1724277-A1 | FUSED HETEROCYCLE DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND MEDICINAL USE THEREOF | Kissei Pharmaceutical Co., Ltd. (JP) | 2006-11-22 | — | — | EP | disclosed |
| EP-1721904-A1 | FUSED HETEROCYCLE DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND MEDICINAL USE THEREOF | Kissei Pharmaceutical Co., Ltd. (JP) | 2006-11-15 | — | — | EP | disclosed |
| US-20060247179-A1 | Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof | KISSEI PHARMACEUTICAL CO., LTD. (JP) | 2006-11-02 | — | — | US | disclosed |
| EP-1609798-A1 | FUSED HETEROCYCLIC DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND MEDICINAL USE THEREOF | Kissei Pharmaceutical Co., Ltd. (JP) | 2005-12-28 | — | — | EP | disclosed |
| US-6558894-B2 | Comprising, on one surface of a support, a photosensitive silver halide, a silver salt of an organic acid, a reducing agent for silver ions, a binder and two or more kinds of organic polyhalogenated compounds | FUJI PHOTO FILM CO., LTD. (JP) | 2003-05-06 | — | — | US | disclosed |
| US-20010021493-A1 | Comprising, on one surface of a support, a photosensitive silver halide, a silver salt of an organic acid, a reducing agent for silver ions, a binder and two or more kinds of organic polyhalogenated compounds | FUJIFILM CORPORATION (JP) | 2001-09-13 | — | — | US | disclosed |